Insider trades
OConnell Daniel Joseph, CEO of Acumen Pharmaceuticals ABOS, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $163.2K. The latest trade was on 01/22.
OConnell Daniel Joseph
CEO
- Company
- Acumen Pharmaceuticals ABOS
- First filing
- 23/01/18
- Trades
- 19 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$163.2K
- Last trade
- 01/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ABOS | Open-market sale | 01/21–01/22 | 01/23 | 12,035 sh2 trades | $1.83avg. | $21,971.58 | −1.3% |
ABOS | Open-market sale | 01/08–01/12 | 01/12 | 26,472 sh3 trades | $1.77avg. | $46,917.66 | −4.3% |
ABOS | Open-market sale | 01/05–01/07 | 01/07 | 47,506 sh3 trades | $1.99avg. | $94,341.92 | −7.1% |
| Open-market sale10b5-1 plan | 25/01/21 | 25/01/23 | 12,619 sh | $1.59 | $20,064.21 | −1.9% | |
| Open-market sale10b5-1 plan | 25/01/03 | 25/01/07 | 47,778 sh | $1.84 | $87,911.52 | −9.5% | |
| Open-market sale10b5-1 plan | 24/01/19 | 24/01/19 | 15,200 sh | $3.47 | $52,744 | −2.9% |